Pyrimidine and Purine Analogs Flashcards
All Pyrimidine Analogs
Fluoruracil (5-FU) Fluxuridine Capecitabine Cytarbine Gemcitabine
5-FU Use
• GI, pancreas, head & neck, colon, rectum, breast, and ovarian cancer
5-FU MOA
- Phosphorylated to 5-FUTP and 5-FdUMP (tight-binding inhibitor of thymidylate synthase)
- Fluororibonucleotides are incorporated into RNA and perturb RNA processing (splicing, transport, translation)
- Fluorodeoxyuridines are incorporated into DNA → strand breaks
5-FU Cytotoxic MOA
5-FU is converted to 5-FdUMP which competes with dUMP for the enzymes thymidylate synthetase
o Normally TS + N5N10 use dUMP to make dTMP but this is blocked by 5-FU
o The N5N10 is then converted to dihydrofolate at the loss of the methyl group to dUMP
FdUMP MOA
o Enzymes tries to use FdUMP making it unable to transfer the methyl group and you end up with a dead end complex because they just get stuck together
5-FU + Leucovorin
- More inihibition of TS → more anticancer effect
* Called “biochemical modulation”
5-FU Side effects
- Bone marrow suppression
- Stomatitis and mucotitis
- N/V
- Cardiac
- Hand & Foot syndrome (lots of rashes on hands and sole of feet)*****
Cytarabine Use
Acute leukemias
Cytarabine Drug Class
Analog of CTP - only difference is the sugar used (arabinose)
Cytarabine MOA
Incorporated into DNA and inhibits chain synthesis via a lack of OH preventing phosphodiester bonds → DNA fragmentation; inhibits DNA polymerase alpha
MOST SPECIFIC FOR S PHASE!!!***
Cytarabine SE
- Severe myelosuppression
- Stomatitis
- Hand & Foot syndrome
Capecitabine Use and MOA
Use: Breast Cancer
MOA: prodrug of 5-FU
Gemcitabine Use
Metastatic pancreatic cancer
Gemcitabine MOA
Phosphorylated to monophosphate then to di and triphosphate
• Triphosphate inhibits DNA polymerases (terminates elongation)
• Diphosphate inhibits ribonucleotide reductase
All PURINE analogs
Fludarabine
Mercaptopurine
Thioguanine
Fludarabine Use
CLL (leukemia)
Fludarabine MOA
- Phosphorylated inhibition of DNA polymerases
* Incorporation into the DNA strand to leads to chain termination
Fludarabine SE
Myelosuppression
Neurotoxicity
Pulmonary toxicity
6-MP MOA
Inhibits the first step in purine biosynthesis
Thioguanine (6-TG) MOA
Incorporated into DNA/RNA and causes fragmentation
6-MP and 6-TG Activation
Activated by HGPRT to toxic nucleotides that inhibit several enzymes involved in purine metabolism
6-MP + Allopurinol MOA
6-MP is metabolized in the liver by xanthine oxidase and the inactive metabolites are excreted
Allopurinol is used frequently to treat/prevent hyperuricemia cause by many anticancer drugs
6-MP + Allopurinol Dosing
If allopurinol is used with 6-MP then the dose of 6-MP has to be reduced by more than 75% to prevent 6-MP induced myelosuppression, hepatotoxicity, mucosititis and hematotoxicity
Fibonucleotide Reductase MOA
Catalyzes conversion of ribonucleotide diphosphates to deoxyribonucleotide diphosphates
Activated prior to DNA synthesis and controlled by feedback inhibition
Hydroxyurea Use and MOA
o Use: leukemia, sickle cell anemia
o MOA: inhibits ribonucleotide reducatase
Inhibits DNA synthesis without affecting RNA synthesis or other nucleotide pools
Downside to hydroxyurea?
Cleared rapidly so not used often